July 24, 2017
Sanofi, Regeneron seek European approval for approval in Europe for Dupinext to treat adults with atopic dermatitis
Sanofi and Regeneron Pharmaceuticals, on Friday announced that the European Medicine Agency`s Committee for Medicinal Products for Human Use has adopted a positive opinion for the marketing authorization of Dupixent.